◆英語タイトル：Vascular Biogenics Ltd (VBLT) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Vascular Biogenics Ltd (VBL Therapeutics) is a biopharmaceutical company. It discovers, develops and commercializes gene-therapy medicines for the treatment of cancer and inflammatory diseases. The company’s lead product candidate VB-111, a gene-based biologic agent is developed to treat recurrent glioblastoma, colon, ovarian, thyroid cancer and solid tumors. Its pipeline products include VB 201 and VB 703, oral small molecules being developed through lecinoxoids platform for treating cardiovascular diseases, liver and renal fibrosis. VBL Therapeutics uses its proprietary vascular targeting system technology to enable systemic administration of gene therapy and improve angiogenic blood vessels. The company is investigating its VB-600 platform targeting MOSPD2 for treating cancers and inflammatory diseases. VBL Therapeutics is headquartered in Modiin, Tel Aviv, Israel.
Vascular Biogenics Ltd Key Recent Developments
Mar 30,2021: VBL Therapeutics to Host Virtual R&D Day on April 6
Mar 25,2021: VBL Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Mar 17,2021: VBL Therapeutics to report fourth quarter and full year financial results on March 25
Nov 16,2020: VBL Therapeutics reports third quarter 2020 financial results and provides corporate update
Oct 13,2020: VBL Therapeutics announces appointment of Marc Kozin as Vice Chairman of Board of Directors
This comprehensive SWOT profile of Vascular Biogenics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vascular Biogenics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Vascular Biogenics Ltd – Key Information
Vascular Biogenics Ltd – Overview
Vascular Biogenics Ltd – Key Employees
Vascular Biogenics Ltd – Key Employee Biographies
Vascular Biogenics Ltd – Key Operational Heads
Vascular Biogenics Ltd – Major Products and Services
Vascular Biogenics Ltd – History
Vascular Biogenics Ltd – Company Statement
Vascular Biogenics Ltd – Locations And Subsidiaries
Vascular Biogenics Ltd
Other Locations & Subsidiaries
Section 2 – Company Analysis
Vascular Biogenics Ltd – Business Description
Vascular Biogenics Ltd – Corporate Strategy
Vascular Biogenics Ltd – SWOT Analysis
SWOT Analysis – Overview
Vascular Biogenics Ltd – Strengths
Vascular Biogenics Ltd – Weaknesses
Vascular Biogenics Ltd – Opportunities
Vascular Biogenics Ltd – Threats
Vascular Biogenics Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
Vascular Biogenics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Vascular Biogenics Ltd, Key Information
Vascular Biogenics Ltd, Key Ratios
Vascular Biogenics Ltd, Share Data
Vascular Biogenics Ltd, Major Products and Services
Vascular Biogenics Ltd, History
Vascular Biogenics Ltd, Key Employees
Vascular Biogenics Ltd, Key Employee Biographies
Vascular Biogenics Ltd, Key Operational Heads
Vascular Biogenics Ltd, Other Locations
Vascular Biogenics Ltd, Subsidiaries
Vascular Biogenics Ltd, Key Competitors
Vascular Biogenics Ltd, SWOT Analysis
Vascular Biogenics Ltd, Ratios based on current share price
Vascular Biogenics Ltd, Annual Ratios
Vascular Biogenics Ltd, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Vascular Biogenics Ltd (VBLT)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら